Cerulean Pharma Inc. (Harvard, MIT) Presents Clinical and Pre-Clinical Nanopharmaceutical Data at EORTC-NCI-AACR (11/18/2010)

Cerulean Pharma Inc., is a biopharmaceutical company focused on the development of nanotechnology-based therapeutics. The company was co-founded by MIT Professor of Health Sciences & Technology and Biological Engineering Ram Sasisekahran and Harvard Medical School Assistant Professor Shiladitya Sengupta.

From the company’s press release:
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that the Company’s senior executives presented at the 22nd EORTC-NCI-AACR Symposium on “Molecular Targets and Cancer Therapeutics,” ongoing in Berlin, Germany. read full press release


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: